Search

everythinglearnresearchcommunity

for

Search:↓

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Dutasteride effectively treats hair loss and prostate issues.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

The document's conclusion cannot be determined without content.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Finasteride does not prevent bladder cancer.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Researchers developed a quick and accurate method to measure finasteride and tamsulosin in tablets.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Blocking progesterone metabolism can cause depression-like behavior in mice.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

Oregano extract helps fix testis and sperm damage caused by finasteride.